Cutting Edge MarinBio Science Newsletter
July 23, 2026
Looking for a partner with 30 years of proven expertise in taking drugs from development to validation and
FDA approval?
Contact us @ 415.883.8000
T Cell-Based Assay Services Looking for T cell-based assay development? Want a GMP-compliant T cell-based assay? Need to develop a custom T cell-based
Cell-Based Assay Services Looking for cell-based assay development? Want a GMP-compliant cell-based assay? Need to develop a custom cell-based potency assay? Need an IND/BLA-ready
Peptide drugs are synthetic short chains of amino acids that mimic natural hormones to manage complex metabolic, endocrine, and oncological conditions. Peptide drugs target
Metabolic-dysfunctional Associated SteatoHepatitis (MASH) is rising globally but effective treatment is limited. It is characterized by inflammation and variable fibrosis, which can progress
Bispecific antibody therapy uses engineered antibodies designed to bind two different targets simultaneously. This dual-targeting ability opens up treatment strategies that arenot possible
The remarkable clinical success of targeted therapies, immunotherapies, antibody-drug conjugates (ADCs), and targeted protein degraders (TPDs) has substantially improved outcomes for many cancer patients.
INTRODUCTION Targeted protein degradation (TPD) has emerged as a transformative therapeutic modality in modern drug discovery. Unlike conventional small-molecule inhibitors, which typically suppress
Introduction Chimeric antigen receptor (CAR) T-cell therapy has demonstrated unprecedented clinical efficacy in the treatment of hematologic malignancies; however, primary resistance and disease relapse
T-cell dysfunction is a major obstacle to effective immunotherapy in cancer, chronic infection, and autoimmune disease, where persistent antigen exposure and immunosuppressive signaling lead
Chimeric antigen receptor (CAR) T-cell therapy has revolutionized treatment for hematologic malignancies, yet its efficacy in solid tumors remains limited by poor persistence, T-cell
The emergence of immune checkpoint inhibitors, adoptive cell therapies, and cancer vaccines has underscored the importance of understanding tumor immunobiology at a systems level.
G Protein-Coupled Receptors (GPCRs) in the Immune System The human genome encodes approximately 800 G protein–coupled receptors (GPCRs), representing a structurally conserved yet
Fibrosis is a final common pathological end-point of chronic injury in multiple organs, characterized by persistent myofibroblast activation, excessive extracellular matrix (ECM) deposition,
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of mortality and morbidity globally. According to the Global Burden of Disease studies, COPD is
Abstract DNA-damaging chemotherapies remain foundational in cancer treatment and are increasingly recognized as potent modulators of anti-tumor immunity. Genotoxic stress activates innate immune
T cells play a central role in immune surveillance by recognizing and eliminating malignant cells, thereby preventing cancer initiation and progression. Through antigen-specific cytotoxic
Introduction Antibody–drug conjugates (ADCs) have emerged as a transformative class of targeted cancer therapies by combining the specificity of monoclonal antibodies with the cytotoxic potency
The development of epigenetic therapeutics marks a fundamental shift in modern drug discovery, moving beyond permanent genetic alterations to target reversible regulatory modifications on
Introduction The development of optogenetics-based gene therapies for inherited retinal diseases represents a transformative strategy for vision restoration but presents unique challenges in pharmaceutical
Download the full article (PDF) MarinBio Blog Diabetes / Liver Cirrhosis & Cancer / Obesity / Dementia This blog will emphasize lifestyle diseases and their
Download the full article (PDF) MarinBio Blog Aqueous humor buildup in glaucoma creates pressure that damages the optic nerve.[/caption] Molecular Trends in Glaucoma Therapy Glaucoma
Introduction Human hematopoietic stem cells (HSCs) are rare, multipotent, self-renewing cells responsible for the lifelong production of all mature blood and immune cell
The advent of CRISPR‑Cas systems has revolutionized the gene therapy landscape, enabling targeted genome editing directly within living organisms (in vivo). Unlike ex vivo
Metabolic diseases, encompassing disorders of carbohydrate, lipid, amino acid, organic acid, mitochondrial, purine/pyrimidine, and endocrine-related metabolism, represent a complex spectrum of inherited and
Antigen-specific tolerance is a fundamental aspect of immune regulation, critical in the context of both autoimmune disease and cancer. In vitro assays using human immune
Download the full article (PDF) Introduction Metabolic diseases comprise a heterogeneous and broad spectrum of inherited or acquired disorders characterized by disruptions in normal biochemical
Download the full article (PDF) Antigen processing sits at a biological crossroads where the immune system decides whether to tolerate or attack. In autoimmune
Download the full article (PDF) Artificial Intelligence has progressed from a supplementary analytics tool to a foundational infrastructure that now supports the full drug discovery
Download the full article (PDF) Introduction Antibodies are cornerstone molecules of adaptive immunity and have become central to therapeutic and diagnostic biotechnology. Classical antibodies
Download the full article (PDF) Introduction The landscape of targeted cancer therapy has expanded dramatically with the advent of sophisticated small-molecule modalities capable of